Convergent Capital is a private investment firm that provides growth and debenture financing to late-stage growth companies. Convergent prefers to commit $2 to $8 million per transaction in businesses with at least $5 million in revenues. Convergent is a generalist investor and will consider businesses in a wide range of industries. Investment funds are typically used to assist growth, but the firm can also structure investments around buyouts, recapitalizations, consolidations, and add-on acquisitions. Convergent is licensed as a SBIC. Convergent Capital was formed in 1998 and is based in Minneapolis, Minnesota.
Join Mergr to view the latest updates and news from Minneapolis-based Convergent Capital.
In the last 3 years, Convergent Capital has acquired 1 company. It has also invested in 1 other.
Convergent Capital’s most common sectors for investment are business services (24%) and manufacturing (18%). The Firm’s most common investment types include growth capital (29%) and buyout (lbo, mbo, mbi) (27%). In total, Convergent Capital has invested in 22 US states.
In the last 3 years, Convergent Capital has exited 1 company. The Firm’s most common exit type is recapitalization (32%). Convergent Capital’s largest (disclosed) exit occurred in 2007 when it sold Healthy Pet for $153M.
Join Mergr to view Convergent Capital’s full profile and discover more small private equity firms just like it.
No obligation. Cancel anytime.